Que pèse la somme de nos lectures dans ce temps
suspendu, et souvent déchiré, qui précède la décision ?
Une bibliothèque n’enferme pas un répertoire de cas,
auxquels nous pourrions tout uniment rapporter notre
situation présente pour découvrir ce que nous avons à
faire. Si les livres devaient nous rendre plus sages, ou
mieux aptes à guider notre existence, le Dalaï Lama serait
professeur de littérature.
Et pourtant : si nous continuons à lire et à accumuler
les volumes autour de nous, c’est bien que les livres
nous aident à vivre à leur façon, que nos lectures ne
restent pas sans effets sur la vie que nous menons. […]]]>
fre
https://serval.unil.ch/resource/serval:BIB_56947888885D.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_56947888885D7
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_56947888885D7
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/openAccess
Copying allowed only for non-profit organizations
https://serval.unil.ch/disclaimer
application/pdf
oai:serval.unil.ch:BIB_5694E7648F91
2022-10-01T01:20:16Z
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:xs="http://www.w3.org/2001/XMLSchema"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
https://serval.unil.ch/notice/serval:BIB_5694E7648F91
The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction.
info:doi:10.1097/SHK.0000000000000963
info:eu-repo/semantics/altIdentifier/doi/10.1097/SHK.0000000000000963
info:eu-repo/semantics/altIdentifier/pmid/29757923
Khan, A.I.
Kapoor, A.
Chen, J.
Martin, L.
Rogazzo, M.
Mercier, T.
Decosterd, L.
Collino, M.
Thiemermann, C.
info:eu-repo/semantics/article
article
2018-06
Shock, vol. 49, no. 6, pp. 675-681
info:eu-repo/semantics/altIdentifier/eissn/1540-0514
urn:issn:1073-2322
<![CDATA[Ischemic heart disease remains the leading cause of morbidity and mortality in the Western world. Artesunate is the WHO-recommended drug of choice for complicated malaria (with organ failure). The administration of high doses of artesunate is safe in healthy volunteers (up to 8 mg/kg i.v.) and patients with severe malaria (2.4 mg/kg i.v.). We investigated the effects of artesunate (1 mg/kg) or its active metabolite dihydroartemisinin (DHA; 0.1 mg/kg) in a model of transient myocardial ischemia/reperfusion (I/R) and evaluated the mechanism of action of the observed cardioprotective effects of artesunate and DHA. We report here for the first time that the administration of artesunate at the onset of reperfusion attenuates the myocardial injury associated with I/R. The observed beneficial effects of artesunate are associated with activation of the PI3K/Akt/ERK 1/2 (RISK) pathway, activation of endothelial nitric oxide synthase, inhibition of glycogen synthase kinase-3β, inhibition of nuclear factor kappa B, and activation of the STAT3 (SAFE) pathway. In conclusion, as artesunate has an excellent safety profile, the above data should stimulate clinical trials in patients with acute coronary syndromes